N. Merker

Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA‐microarray from primary clinical samples

C. Heussel, T. Boch, W. Hofmann, 2015, Mycoses.

Bullying in School: Case Study of Prevention and Psycho-Pedagogical Correction

Laysan A. Ribakova, R. Valeeva, N. Merker, 2016 .

Incidence of Cyp51 A Key Mutations in Aspergillus fumigatus—A Study on Primary Clinical Samples of Immunocompromised Patients in the Period of 1995–2013

W. Hofmann, T. Miethke, M. Hoenigl, 2014, PloS one.

Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.

T. Boch, W. Hofmann, S. Krause, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Development of Novel PCR Assays To Detect Azole Resistance-Mediating Mutations of the Aspergillus fumigatus cyp51A Gene in Primary Clinical Samples from Neutropenic Patients

W. Hofmann, D. Buchheidt, S. Howard, 2012, Antimicrobial Agents and Chemotherapy.

Comparison of Two Molecular Assays for Detection and Characterization of Aspergillus fumigatus Triazole Resistance and Cyp51A Mutations in Clinical Isolates and Primary Clinical Samples of Immunocompromised Patients

T. Boch, W. Hofmann, T. Miethke, 2018, Front. Microbiol..

Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA‐microarray from primary clinical samples

T. Boch, M. Hoenigl, D. Buchheidt, 2015, Mycoses.